JDRF Blog

FDA Authorizes a Second Artificial Pancreas System

The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced hybrid closed...

Join Us "Inside the Lab at Boston"

The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a bit shrouded...

JDRF Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research

Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

Glen Tullman, JDRF Director Emeritus and Livongo Health Founder honored with the RFK Human Rights Ripple of Hope Award

December 13, 2019

Thank you for being T1D Champions

December 3, 2019

State of the Foundation: Inspiring T1D Champions | Accelerating Cures

November 20, 2019

Insulin Affordability Matters: Advocating to Make Insulin More Affordable for All

November 14, 2019

More than 1.25 million Americans live with type 1 diabetes (T1D), and this number continues to grow. They need insulin several times...

JDRF Research Strategy: Cures and Improving Lives

May 31, 2019

They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

The 20th Anniversary of the Edmonton Protocol

March 11, 2019

This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

Spring Break Travel with #T1DTech

February 7, 2020

Whether you’re taking a road trip or a cross-country red eye flight, traveling with your #T1DTech can certainly present some extra challenges but that shouldn’t stop you from enjoying the experience. Preparing ahead of time will allow you to relax a little more and enjoy your spring break trip to the fullest!